252 related articles for article (PubMed ID: 17293886)
1. Inhibitors of monoacylglycerol lipase as novel analgesics.
Hohmann AG
Br J Pharmacol; 2007 Mar; 150(6):673-5. PubMed ID: 17293886
[TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
3. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
5. Fatty pain cures.
Imming P
Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
[TBL] [Abstract][Full Text] [Related]
6. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
Chicca A; Marazzi J; Gertsch J
Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
[TBL] [Abstract][Full Text] [Related]
8. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
Gomez O; Arevalo-Martin A; Garcia-Ovejero D; Ortega-Gutierrez S; Cisneros JA; Almazan G; Sánchez-Rodriguez MA; Molina-Holgado F; Molina-Holgado E
Glia; 2010 Dec; 58(16):1913-27. PubMed ID: 20878765
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
10. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
Alhouayek M; Lambert DM; Delzenne NM; Cani PD; Muccioli GG
FASEB J; 2011 Aug; 25(8):2711-21. PubMed ID: 21551239
[TBL] [Abstract][Full Text] [Related]
11. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
Wilkerson JL; Niphakis MJ; Grim TW; Mustafa MA; Abdullah RA; Poklis JL; Dewey WL; Akbarali H; Banks ML; Wise LE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Apr; 357(1):145-56. PubMed ID: 26791602
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
Du H; Chen X; Zhang J; Chen C
Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147
[TBL] [Abstract][Full Text] [Related]
14. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
15. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
Thomas A; Okine BN; Finn DP; Masocha W
Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
[TBL] [Abstract][Full Text] [Related]
16. An endocannabinoid mechanism for stress-induced analgesia.
Hohmann AG; Suplita RL; Bolton NM; Neely MH; Fegley D; Mangieri R; Krey JF; Walker JM; Holmes PV; Crystal JD; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
Nature; 2005 Jun; 435(7045):1108-12. PubMed ID: 15973410
[TBL] [Abstract][Full Text] [Related]
17. Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats.
Shimizu T; Lu L; Yokotani K
Eur J Pharmacol; 2011 May; 658(2-3):123-31. PubMed ID: 21371452
[TBL] [Abstract][Full Text] [Related]
18. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
Long JZ; Li W; Booker L; Burston JJ; Kinsey SG; Schlosburg JE; Pavón FJ; Serrano AM; Selley DE; Parsons LH; Lichtman AH; Cravatt BF
Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
[TBL] [Abstract][Full Text] [Related]
20. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]